Filing Summary
Registrant: Flora Growth Corp., not Zerostack Corp. The submitted Form 6-K covers July 2022 and reports the results of Flora Growth’s 2022 Annual and Special Meeting of Shareholders held on July 5, 2022. The report was signed and filed on July 6, 2022.
Business Context and Reporting Period
The filing concerns shareholder voting and corporate governance matters. A total of 27,106,410 common shares voted, representing approximately 35.2% of outstanding shares and constituting a valid quorum.
Financial and Operating Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating financial metrics. It is not a financial-results filing.
Meeting Results and Material Actions
| Proposal | Result | Votes For | Votes Against | Abstentions |
|---|---|---|---|---|
| Election of seven directors | All nominees elected | 17,855,123–26,775,580 | 164,519–9,098,008 | 138,053–8,288,143 |
| Ratification of Davidson & Company LLP as independent auditor for fiscal 2022 | Approved | 26,645,485 | 82,266 | 378,659 |
| 2022 Incentive Compensation Plan | Approved | 17,449,649 | 9,132,816 | 523,945 |
| Repeal of prior by-law and ratification of Bylaw No. 1-A | Approved | 26,523,706 | 230,826 | 351,878 |
Guidance, Outlook, Risks, and Unusual Items
The filing provides no financial guidance or business outlook. The 2022 Incentive Compensation Plan was approved, and Bylaw No. 1-A was confirmed and ratified. No other matters were considered or voted upon. The filing does not identify material contingencies or unusual financial items.
Important Facts to Verify
- Confirm the company identity: the source filing is for Flora Growth Corp., while the request metadata identifies Zerostack Corp.
- Review the filed 2022 Incentive Compensation Plan, attached as Exhibit 99.2, for dilution and award terms.
- Review Bylaw No. 1-A, attached as Exhibit 99.3, for changes to governance provisions.
- Assess the relatively low participation rate of approximately 35.2% of outstanding shares and the substantial abstentions on certain director nominees and the incentive plan.
- Verify subsequent filings for financial results, capital structure changes, compensation-plan awards, and governance developments.